Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 13,868 |
|
|||||
| News | - | ||||||
| Day High | 0.629 | Low High |
|||||
| Day Low | 0.57 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Forte Biosciences Inc | FBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.60 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.57 | 0.57 | 0.629 | 0.60 | 0.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 135 | 13,868 | $ 0.5941673 | $ 8,240 | - | 0.38 - 1.0599 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | formt | 610 | $ 0.63 | USD |
Forte Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.78M | 36.34M | - | 0 | -31.48M | -0.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Forte Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FBRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.655 | 0.7485 | 0.5101 | 0.6085381 | 28,810 | -0.055 | -8.40% |
| 1 Month | 0.725 | 0.769899 | 0.5101 | 0.6634551 | 17,683 | -0.125 | -17.24% |
| 3 Months | 0.6984 | 0.78 | 0.5101 | 0.6996408 | 24,375 | -0.0984 | -14.09% |
| 6 Months | 0.4494 | 0.85 | 0.4275 | 0.6809271 | 32,513 | 0.1506 | 33.51% |
| 1 Year | 0.9839 | 1.0599 | 0.38 | 0.7960682 | 45,912 | -0.3839 | -39.02% |
| 3 Years | 38.00 | 43.57 | 0.38 | 6.22 | 307,094 | -37.40 | -98.42% |
| 5 Years | 17.00 | 53.99 | 0.38 | 8.95 | 260,054 | -16.40 | -96.47% |
Forte Biosciences Description
| Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial. |
